PRICE T ROWE ASSOCIATES INC 13D and 13G filings for EyePoint Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 1:22 pm Sale | 2024-09-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | PRICE T ROWE ASSOCIATES INC | 2,492,213 4.700% | -30,491 (-1.21%) | Filing |
| 2024-02-14 10:02 am Purchase | 2023-12-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | PRICE T ROWE ASSOCIATES INC | 2,522,704 5.600% | 2,522,704 (New Position) | Filing |